EE380 Budget-Impact Analysis of Encorafenib with Binimetinib for Unresectable or Metastatic Melanoma in BRAFV600-Mutated Patients in an Argentinian Social Security Payer Setting
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.646
https://www.valueinhealthjournal.com/article/S1098-3015(23)03776-2/fulltext
Title :
EE380 Budget-Impact Analysis of Encorafenib with Binimetinib for Unresectable or Metastatic Melanoma in BRAFV600-Mutated Patients in an Argentinian Social Security Payer Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03776-2&doi=10.1016/j.jval.2023.09.646
First page :
Section Title :
Open access? :
No
Section Order :
10130